GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 8/14/2026 5:14:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $76,156 -96.6% | Assets $8,726,423 | EPS -$0.12 | |
| BioNexus Gene Lab Corp (BGLC) | 5/15/2026 5:21:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $22,842 -98.9% | Assets $9,040,130 | EPS -$0.23 | |
| BioNexus Gene Lab Corp (BGLC) | 4/14/2026 5:31:39 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $7,424,911 -21.9% | Assets $9,252,784 | EPS -$1.61 | |
| BioNexus Gene Lab Corp (BGLC) | 12/3/2025 5:16:19 PM | View | Proxy | SEC | Y 2024 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 11/14/2025 5:33:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $2,543,823 -3.3% | Assets $7,621,228 | EPS -$0.40 | |
| BioNexus Gene Lab Corp (BGLC) | 8/18/2025 4:54:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $2,260,253 +14.5% | Assets $9,421,205 | EPS -$0.34 | |
| BioNexus Gene Lab Corp (BGLC) | 5/15/2025 4:44:33 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $2,137,075 -10.3% | Assets $9,479,939 | EPS -$0.04 | |
| BioNexus Gene Lab Corp (BGLC) | 4/29/2025 3:35:31 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,510,646 -2.7% | Assets $10,433,848 | EPS -$0.09 | |
| BioNexus Gene Lab Corp (BGLC) | 4/15/2025 11:14:12 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,510,646 -2.7% | Assets $10,433,848 | EPS -$0.09 | |
| BioNexus Gene Lab Corp (BGLC) | 2/28/2025 6:07:18 AM | View | Proxy | SEC | Y 2024 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 2/27/2025 5:20:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 11/15/2024 5:10:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,630,376 +3.0% | Assets $10,995,055 | ||
| BioNexus Gene Lab Corp (BGLC) | 9/16/2024 5:21:41 PM | View | Proxy | SEC | Y 2023 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 8/14/2024 2:28:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,974,564 -23.1% | Assets $11,139,727 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/31/2024 4:05:30 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $9,770,806 -10.6% | Assets $11,399,793 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/31/2024 4:05:30 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $2,553,686 -0.8% | Assets $11,465,522 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/31/2024 4:05:30 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $2,566,848 +3.3% | Assets $7,898,940 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/31/2024 4:05:29 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $2,377,205 -21.5% | Assets $8,186,641 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/31/2024 4:05:28 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $10,928,707 -18.2% | Assets $8,740,162 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/15/2024 1:36:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,381,851 +0.2% | Assets $11,161,483 | ||
| BioNexus Gene Lab Corp (BGLC) | 4/16/2024 1:19:25 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $9,770,806 -10.6% | Assets $11,399,793 | ||
| BioNexus Gene Lab Corp (BGLC) | 3/26/2024 4:16:14 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $2,553,686 -0.8% | Assets $11,465,522 | ||
| BioNexus Gene Lab Corp (BGLC) | 2/29/2024 5:19:25 PM | View | Proxy | SEC | Y 2023 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 8/16/2023 11:35:35 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $2,566,848 +3.3% | Assets $7,898,940 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/17/2023 9:08:20 AM | View | Proxy | SEC | Y 2022 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 5/9/2023 11:51:03 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $2,377,205 -21.5% | Assets $8,186,641 | ||
| BioNexus Gene Lab Corp (BGLC) | 3/31/2023 10:10:47 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $10,928,707 -18.2% | Assets $8,740,162 | ||
| BioNexus Gene Lab Corp (BGLC) | 3/10/2023 10:35:52 AM | View | Proxy | SEC | Y 2022 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 2/21/2023 4:19:13 PM | View | Proxy | SEC | Y 2022 | ||||||
| BioNexus Gene Lab Corp (BGLC) | 11/14/2022 4:58:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $2,575,086 -28.0% | Assets $7,798,236 | ||
| BioNexus Gene Lab Corp (BGLC) | 8/15/2022 4:10:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $2,485,101 -19.6% | Assets $8,368,713 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/16/2022 8:37:19 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $3,028,945 -12.2% | Assets $9,175,422 | ||
| BioNexus Gene Lab Corp (BGLC) | 4/6/2022 8:26:34 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $13,362,567 +17.3% | Assets $9,574,390 | ||
| BioNexus Gene Lab Corp (BGLC) | 11/15/2021 7:04:46 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $3,575,966 +15.7% | Assets $9,765,004 | ||
| BioNexus Gene Lab Corp (BGLC) | 8/12/2021 10:25:59 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $3,092,171 +180.2% | Assets $9,448,123 | ||
| BioNexus Gene Lab Corp (BGLC) | 5/18/2021 10:24:57 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $3,449,159 +12.3% | Assets $9,898,531 | ||
| BioNexus Gene Lab Corp (BGLC) | 3/30/2021 5:46:00 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $11,390,440 +8,872.0% | Assets $10,115,293 | ||
| BioNexus Gene Lab Corp (BGLC) | 11/9/2020 9:24:10 AM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $3,091,012 +12,687.0% | Assets $1,013,219 | ||
| BioNexus Gene Lab Corp (BGLC) | 11/3/2020 9:33:03 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $3,091,012 +12,687.0% | Assets $1,013,219 | ||
| BioNexus Gene Lab Corp (BGLC) | 8/11/2020 9:53:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $1,103,516 +4,998.2% | Assets $1,060,241 | ||
| BioNexus Gene Lab Coporation (BGLC) | 5/8/2020 11:47:55 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $3,070,026 +10,830.0% | Assets $1,126,915 | ||
| BioNexus Gene Lab Coporation (BGLC) | 3/31/2020 1:23:48 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $126,955 -40.2% | Assets $1,231,236 | ||
| BioNexus Gene Lab Coporation (BGLC) | 11/14/2019 10:07:43 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $24,173 -73.6% | Assets $1,344,403 | ||
| BioNexus Gene Lab Coporation (BGLC) | 8/9/2019 3:38:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $21,645 -80.6% | Assets $1,512,903 | ||
| BioNexus Gene Lab Coporation (BGLC) | 5/15/2019 1:33:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $28,088 | Assets $1,607,160 |